ONCT to $6.50Price at bottom channel
Stochastic Momentum Index (SMI) at oversold level
TTM Squeeze momentum is down
Price at Fibonacci number
In @$4.31
ONCT trade ideas
$ONCT Oncternal Therapeutics Inc Target PT 11 and higherNASDAQ:ONCT Oncternal Therapeutics Inc
Target PT 11 and higher
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins, which is in Phase 1/2 clinical trial. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T), which is in Phase 1/2 clinical trial for the treatment of hematologic malignancies and solid tumors, as well as targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate in preclinical development for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.
Hitting the bottom of trend line.$ONCT there is a clear trend line and it seems to have strong support in 6.2 zone. Play for 10-15 percent bounce from here.
Oncternal Therapeutic ONCT - Bullish betThis small-cap is a long-time leader in the oncology industry and has been highly rated by analysts in recent weeks.
Oncternal Therapeutics, Inc. (ONCT) Q4 2020 Earnings Call Transcript: www.fool.com
Interesting analysis: stocksregister.com
ONCT=free money playbeautiful play to swing trade if you enter on bottom trendline dip! has been rejected off top trendline resistance 4 times in previous months so be cautious when entering here! of course resistance will turn into support if 10 breaks so be on the lookout for a bigger breakout!
ONCT: Bullish Pennant (50%)Bullish Pennant (50%)
Pros:
Volume during post formation
Descending volume during triangle formation
PPS above 50MA and 200MA
RS above 0 and ascending
ATR Ascending
R/R ratio above 5
250RSI above 50 and ascending
200MA ascending
Target:
PT = 20.10$
Help how ever you can to keep this alive.
Thank you to those who have donated Coins!
Always do your own due dilligence. This is not financial advice
Stay Humble, have fun, make money!
Education:
www.dailyfx.com
$ONCT making a push above $6.30, maybe above $8The RSI has yet to break its overbought threshold, it never fell back into the gap, it closed above the Bollinger Bands upper and the upper intersects a bullish trend line. I'm betting on this one to run LONG into that resistance line.
The awaiting was worthedTriangle pattern followed by the breakout. Target price $8 USD 40.85% upside potential
ONCT LONG TAKE PROFITS AROUND 5.70, RE-ENTER AROUND 5LONG BUT TAKING SOME PROFITS HERE NOW AND RE-ENTERING AROUND 5
nice free money play herewe have made a good amount of money off this ticker in the past, and i didnt even know ark was in when we got it the first time.. looking to enter over 5.2 with stop loss at 4. price target after entry would be 8-10. great risk reward here. goodluck to longs :)
ONCT crossing above a crucial levelONCT has reached a crucial level on the eve of earnings news.
It might crash down if it can't hold above this level or it might climb to $8.2 if it can hold above this level.
Earnings call on Thursday will fuel the move up or down.
Position will be based on the next couple days.
